Table III.
Formula code | Formulations | Release rate constant | Correlation coefficient (r) | Higuchi (r) | T 50% (h) | |
---|---|---|---|---|---|---|
Zero-order k 0% (day−1) | First-order k 1 (day −1) | |||||
F1 | Rifampicin | 131.53 ± 16.14 | – | 0.9816 ± 0.07 | 0.9640 ± 0.04 | 10.98 ± 0.03 |
F2 | R/mPEG2000–DSPE (1:5)/0.45 | – | 1.10 ± 0.07 | 0.9897 ± 0.01 | 0.9780 ± 0.01 | 17.06 ± 0.02 |
F3 | R/mPEG2000–DSPE (1:10)/0.45 | – | 1.31 ± 0.22 | 0.9923 ± 0.01 | 0.9772 ± 0.01 | 16.52 ± 0.06 |
F4 | R/mPEG2000–DSPE (1.5:10)/0.45 | – | 0.82 ± 0.03 | 0.9954 ± 0.01 | 0.9890 ± 0.01 | 20.88 ± 0.03 |
F5 | R/mPEG2000–DSPE (1:5)/0.22 | – | 2.14 ± 0.05 | 0.9843 ± 0.02 | 0.9489 ± 0.02 | 11.78 ± 0.04 |
F6 | R/mPEG2000–DSPE (1:10)/0.22 | – | 1.56 ± 0.26 | 0.9695 ± 0.03 | 0.9411 ± 0.02 | 10.95 ± 0.02 |
F7 | R/mPEG2000–DSPE (1.5:10)/0.22 | – | 2.40 ± 0.25 | 0.9759 ± 0.02 | 0.9452 ± 0.03 | 12.83 ± 0.07 |
F8 | R/mPEG5000–DSPE (1:5)/0.45 | – | 1.04 ± 0.08 | 0.9944 ± 0.01 | 0.9794 ± 0.01 | 20.10 ± 0.05 |
F9 | R/mPEG5000–DSPE (1:10)/0.45 | – | 1.29 ± 0.21 | 0.9950 ± 0.01 | 0.9849 ± 0.01 | 18.54 ± 0.01 |
F10 | R/mPEG5000–DSPE (1.5:10)/0.45 | – | 0.76 ± 0.02 | 0.9777 ± 0.03 | 0.9627 ± 0.03 | 22.10 ± 0.03 |
F11 | R/mPEG5000–DSPE (1:5)/0.22 | – | 1.44 ± 0.31 | 0.9786 ± 0.01 | 0.9560 ± 0.02 | 12.94 ± 0.05 |
F12 | R/mPEG5000–DSPE (1:10)/0.22 | – | 1.49 ± 0.02 | 0.9476 ± 0.03 | 0.9414 ± 0.01 | 11.74 ± 0.03 |
F13 | R/mPEG5000–DSPE (1.5:10)/0.22 | – | 1.63 ± 0.52 | 0.9699 ± 0.04 | 0.9540 ± 0.02 | 13.63 ± 0.01 |
Mean ± SD; N = 3